Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Expert Opinion on Drug Discovery
|
September 9, 2014
New approaches to the design and discovery of therapies to prevent erectile dysfunction
Haroldo A Toque, Robert William Caldwell
Trends in Pharmacological Sciences
|
May 2, 2015
Arginase: an old enzyme with new tricks
Ruth B Caldwell, Haroldo A Toque, S Priya Narayanan, et al.
Life Sciences
|
October 17, 2017
Toll-like receptor 4 (TLR4) impairs nitric oxide contributing to Angiotensin II-induced cavernosal dysfunction
Kenia P Nunes, Gisele F Bomfim, Haroldo A Toque, et al.
European Journal of Pharmacology
|
July 31, 2010
Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle
Haroldo A Toque, Fabíola Z T Mónica, Rafael P Morganti, et al.
Physiological Reviews
|
February 8, 2018
Arginase: A Multifaceted Enzyme Important in Health and Disease
R William Caldwell, Paulo C Rodriguez, Haroldo A Toque, et al.
The Journal of Sexual Medicine
|
October 15, 2011
Extracellular signal-regulated kinase (ERK) inhibition decreases arginase activity and improves corpora cavernosal relaxation in streptozotocin (STZ)-induced diabetic mice
Kenia P Nunes, Haroldo A Toque, Ruth B Caldwell, et al.
European Journal of Pharmacology
|
December 4, 2018
Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways
Surabhi Chandra, David J R Fulton, Ruth B Caldwell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 6, 2015
Beneficial effect of the soluble guanylyl cyclase stimulator BAY 41-2272 on impaired penile erection in db/db-/- type II diabetic and obese mice
Kenia Pedrosa Nunes, Cleber E Teixeira, Fernanda B M Priviero, et al.
Journal of Cardiovascular Disease Research
|
January 26, 2011
The role of RhoA/Rho kinase pathway in endothelial dysfunction
Lin Yao, Maritza J Romero, Haroldo A Toque, et al.
European Journal of Pharmacology
|
July 3, 2008
Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum
Haroldo A Toque, Cleber E Teixeira, Raquel Lorenzetti, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Expert Opinion on Drug Discovery
|
September 9, 2014
New approaches to the design and discovery of therapies to prevent erectile dysfunction
Haroldo A Toque, Robert William Caldwell
Trends in Pharmacological Sciences
|
May 2, 2015
Arginase: an old enzyme with new tricks
Ruth B Caldwell, Haroldo A Toque, S Priya Narayanan, et al.
Life Sciences
|
October 17, 2017
Toll-like receptor 4 (TLR4) impairs nitric oxide contributing to Angiotensin II-induced cavernosal dysfunction
Kenia P Nunes, Gisele F Bomfim, Haroldo A Toque, et al.
European Journal of Pharmacology
|
July 31, 2010
Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle
Haroldo A Toque, Fabíola Z T Mónica, Rafael P Morganti, et al.
Physiological Reviews
|
February 8, 2018
Arginase: A Multifaceted Enzyme Important in Health and Disease
R William Caldwell, Paulo C Rodriguez, Haroldo A Toque, et al.
The Journal of Sexual Medicine
|
October 15, 2011
Extracellular signal-regulated kinase (ERK) inhibition decreases arginase activity and improves corpora cavernosal relaxation in streptozotocin (STZ)-induced diabetic mice
Kenia P Nunes, Haroldo A Toque, Ruth B Caldwell, et al.
European Journal of Pharmacology
|
December 4, 2018
Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways
Surabhi Chandra, David J R Fulton, Ruth B Caldwell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 6, 2015
Beneficial effect of the soluble guanylyl cyclase stimulator BAY 41-2272 on impaired penile erection in db/db-/- type II diabetic and obese mice
Kenia Pedrosa Nunes, Cleber E Teixeira, Fernanda B M Priviero, et al.
Journal of Cardiovascular Disease Research
|
January 26, 2011
The role of RhoA/Rho kinase pathway in endothelial dysfunction
Lin Yao, Maritza J Romero, Haroldo A Toque, et al.
European Journal of Pharmacology
|
July 3, 2008
Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum
Haroldo A Toque, Cleber E Teixeira, Raquel Lorenzetti, et al.
Page
of 4